- Survivors pulled from Oklahoma tornado debris as toll falls |
- Analysis: Some Republicans see new scandal in Sebelius fundraising
- Convicted U.S. killer Arias would join tiny death row group
- Drop in U.S. underground water levels has accelerated -USGS
- Israel fires back at Syria after gunshots at its troops
Teva lupus drug fails in clinical trial
NEW YORK, Sept 19 |
NEW YORK, Sept 19 (Reuters) - Israel's Teva Pharmaceuticals Industries Ltd TEVA.O said on Wednesday that its experimental treatment for lupus failed to meet the goal of a mid-stage clinical trial.
The drug, edratide, administered by subcutaneous weekly injection, appeared to be safe and well-tolerated but failed to reduce lupus disease activity over a 26-week treatment period, Teva said.
Analysis of secondary goals of the 340-patient study was still ongoing, Teva said. The company said any further development plans for edratide will be determined once those analyses have been completed. (Reporting by Bill Berkrot)
- Tweet this
- Share this
- Digg this